BRCA1 and neoplasm: As ADAR1 suppresses dsRNA sensing innate immune responses through RNA editing3, and tumor cell lines with an elevated interferon-stimulated gene (ISG) signature are sensitive to ADAR1 silencing11–13, we sought to test whether cytosolic nucleic acid sensing might also contribute to the BRCA1/2–ADAR1 SL effects.